Combination treatment could provide new standard-of-care for aggressive lymphoma
By Catherine Eckford (European Pharmaceutical Review)
MHRA publishes strategy on AI regulation
By Catherine Eckford (European Pharmaceutical Review)
Long-acting antibody demonstrates promising efficacy in infant RSV
By Catherine Eckford (European Pharmaceutical Review)
From viral vectors to nucleic acids: biopharma’s evolving manufacturing landscape
By Caroline Peachey (European Pharmaceutical Review)
What is the future of biologic medicines?
By Catherine Eckford (European Pharmaceutical Review), Sigma Mostafa (KBI Biopharma)